VE-cadherin-CreERT2 transgenic mouse: A model for inducible recombination in the endothelium

Developmental Dynamics

Volumn 235, Issue 12, 2006, Pages 3413-3422

  Monvoisin, Arnaud ^a   Alva, Jackelyn A ^a   Hofmann, Jennifer J ^a   Zovein, Ann C ^a   Lane, Timothy F ^a,b   Iruela Arispe, M Luisa ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cadherin 5; Cre recombinase; Endothelium; Tamoxifen; Transgenic mice; Tumor angiogenesis; VE cadherin

Indexed keywords

BETA GALACTOSIDASE; CRE RECOMBINASE; TAMOXIFEN; VASCULAR ENDOTHELIAL CADHERIN; CADHERIN; INTEGRASE; LEUKOCYTE ANTIGEN;

ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; CELL LINEAGE; CONTROLLED STUDY; EMBRYO; ENDOTHELIUM; GENE CASSETTE; GENE EXPRESSION; GENETIC RECOMBINATION; HEMATOPOIETIC CELL; MOUSE; MOUSE STRAIN; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; REPORTER GENE; TISSUE SPECIFICITY; TRANSGENIC MOUSE; TUMOR VASCULARIZATION; ANIMAL; BIOLOGICAL MODEL; C57BL MOUSE; DRUG EFFECT; FEMALE; GENETICS; GROWTH, DEVELOPMENT AND AGING; MALE; METABOLISM; PREGNANCY; PRENATAL DEVELOPMENT; VASCULAR ENDOTHELIUM;

ANIMALIA; MUS MUSCULUS;

ANIMALS; ANIMALS, NEWBORN; ANTIGENS, CD; CADHERINS; ENDOTHELIUM, VASCULAR; FEMALE; GENES, REPORTER; INTEGRASES; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MODELS, GENETIC; PREGNANCY; RECOMBINATION, GENETIC; TAMOXIFEN;

EID: 33845357881     PISSN: 10588388     EISSN: 10970177     Source Type: Journal    
DOI: 10.1002/dvdy.20982     Document Type: Article

References (23)

1. Alva JA, Zovein AC, Monvoisin A, Murphy T, Salazar A, Harvey NL, Carmeliet P, Iruela-Arispe ML. 2006. VE-Cadherin-Cre-recombinase transgenic mouse: a tool for lineage analysis and gene deletion in endothelial cells. Dev Dyn 235:759-767.
2. Danielian PS, White R, Hoare SA, Fawell SE, Parker MG. 1993. Identification of residues in the estrogen receptor that confer differential sensitivity to estrogen and hydroxytamoxifen. Mol Endocrinol 7:232-240.
3. Feil R, Brocard J, Mascrez B, LeMeur M, Metzger D, Chambon P. 1996. Ligand-activated site-specific recombination in mice. Proc Natl Acad Sci U S A 93:10887-10890.
4. Feil R, Wagner J, Metzger D, Chambon P. 1997. Regulation of Cre recombinase activity by mutated estrogen receptor ligand-binding domains. Biochem Biophys Res Commun 237:752-757.
5. Forde A, Constien R, Grone HJ, Hammerling G, Arnold B. 2002. Temporal Cre-mediated recombination exclusively in endothelial cells using Tie2 regulatory elements. Genesis 33:191-197.
6. Gory S, Vernet M, Laurent M, Dejana E, Dalmon J, Huber P. 1999. The vascular endothelial-cadherin promoter directs endothelial-specific expression in transgenic mice. Blood 93:184-192.
7. Gothert JR, Gustin SE, Hall MA, Green AR, Gottgens B, Izon DJ, Begley CG. 2005. In vivo fate-tracing studies using the Scl stem cell enhancer: embryonic hematopoietic stem cells significantly contribute to adult hematopoiesis. Blood 105:2724-2732.
8. Gustafsson E, Brakebusch C, Hietanen K, Fassler R. 2001. Tie-1-directed expression of Cre recombinase in endothelial cells of embryoid bodies and transgenic mice. J Cell Sci 114:671-676.
9. Hayashi S, McMahon AP. 2002. Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation/inactivation in the mouse. Dev Biol 244:305-318.
10. Imai T, Jiang M, Chambon P, Metzger D. 2001. Impaired adipogenesis and lipolysis in the mouse upon selective ablation of the retinoid X receptor alpha mediated by a tamoxifen-inducible chimeric Cre recombinase (Cre-ERT2) in adipocytes. Proc Natl Acad Sci U S A 98:224-228.
11. Kisanuki YY, Hammer RE, Miyazaki J, Williams SC, Richardson JA, Yanagisawa M. 2001. Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo. Dev Biol 230:230-242.
12. Lee MJ, Thangada S, Claffey KP, Ancellin N, Liu CH, Kluk M, Volpi M, Sha'afi RI, Hla T. 1999. Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate. Cell 99:301-312.
13. Leone DP, Genoud S, Atanasoski S, Grausenburger R, Berger P, Metzger D, Macklin WB, Chambon P, Suter U. 2003. Tamoxifen-inducible glia-specific Cre mice for somatic mutagenesis in oligodendrocytes and Schwann cells. Mol Cell Neurosci 22:430-440.
14. Mattioni T, Louvion JF, Picard D. 1994. Regulation of protein activities by fusion to steroid binding domains. Methods Cell Biol 43(Pt A):335-352.
15. Metzger D, Chambon P. 2001. Site- and time-specific gene targeting in the mouse. Methods 24:71-80.
16. Metzger D, Ali S, Bornert JM, Chambon P. 1995. Characterization of the amino-terminal transcriptional activation function of the human estrogen receptor in animal and yeast cells. J Biol Chem 270:9535-9542.
17. Motoike T, Markham DW, Rossant J, Sato TN. 2003. Evidence for novel fate of Flk1+ progenitor: contribution to muscle lineage. Genesis 35:153-159.
18. Nolan GP, Fiering S, Nicolas JF, Herzenberg LA. 1988. Fluorescence-activated cell analysis and sorting of viable mammalian cells based on beta-D-galactosidase activity after transduction of Escherichia coli lacZ. Proc Natl Acad Sci U S A 85:2603-2607.
19. Orban PC, Chui D, Marth JD. 1992. Tissue- and site-specific DNA recombination in transgenic mice. Proc Natl Acad Sci U S A 89:6861-6865.
20. Picard D. 1994. Regulation of protein function through expression of chimaeric proteins. Curr Opin Biotechnol 5:511-515.
21. Sauer B. 1998. Inducible gene targeting in mice using the Cre/lox system. Methods 14:381-392.
22. Soriano P. 1999. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat Genet 21:70-71.
23. Vasioukhin V, Degenstein L, Wise B, Fuchs E. 1999. The magical touch: genome targeting in epidermal stem cells induced by tamoxifen application to mouse skin. Proc Natl Acad Sci U S A 96:8551-5556.